{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T08:28:09Z","timestamp":1769502489309,"version":"3.49.0"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"13","license":[{"start":{"date-parts":[[2021,4,2]],"date-time":"2021-04-02T00:00:00Z","timestamp":1617321600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Startup Fund for scientific research, Fujian Medical University","award":["2019QH1075"],"award-info":[{"award-number":["2019QH1075"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Rationale:<\/jats:title>\n            <jats:p>Glioblastoma is the most lethal and common malignant brain tumor but rare in patients with neurofibromatosis type 1. The clinical findings and pathological findings with gene signatures in female patients have not been well clarified.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 51-year-old female patient complained of headache and left limb weakness lasting for 20\u200adays. The patient underwent a cesarean section 20\u200ayears ago and hysterectomy 1\u200ayear ago because of uterine leiomyomas. Multiple caf\u00e9-au-lait spots and neurofibromas were found over patient's chest, neck, back, and arms. The myodynamia of left distant and proximate epipodite were grade 0 and grade 1 respectively. The myodynamia of lower left limb was grade 3.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnoses:<\/jats:title>\n            <jats:p>Magnetic resonance imaging revealed a malignant lesion which was most likely a glioblastoma in the right temporo-parietal lobe, approximately 5.6 \u00d7 5.9 \u00d7 6.9 cm in size with a rounded boundary.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>A right temporo-parietal craniotomy was performed to resect the space-occupying lesion for gross total removal. Then, the patient received concurrent chemoradiotherapy. Histological examination confirmed a glioblastoma without v-RAF murine sarcoma viral oncogene homolog B1 gene, isocitrate dehydrogenase 1 gene, and telomerase reverse transcriptase gene promoter mutations.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>After surgery, the headache was relieved and the muscular strength of left limbs did improve. After receiving the standard treatment regimen, the patient was alive at 13\u200amonths follow-up.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Lessons:<\/jats:title>\n            <jats:p>This is the first reported glioblastoma in female neurofibromatosis type 1 patient without v-RAF murine sarcoma viral oncogene homolog B1 gene, isocitrate dehydrogenase 1 gene, and telomerase reverse transcriptase gene promoter mutations. Tumors in adult patients with these signatures were less aggressive with well-circumscribed border and had long-term survivals which strengthened the evidence that these patients may comprise a unique subset in glioblastoma.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000025346","type":"journal-article","created":{"date-parts":[[2021,3,31]],"date-time":"2021-03-31T13:11:50Z","timestamp":1617196310000},"page":"e25346","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Glioblastoma in a female neurofibromatosis 1 patient without IDH1, BRAF V600E, and TERT promoter mutations"],"prefix":"10.1097","volume":"100","author":[{"given":"Jia-Wei","family":"Cai","sequence":"first","affiliation":[{"name":"Department of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiao-Yong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-Yuan","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian, People's Republic of China."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zan-Yi","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xi-Yue","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Hong","family":"Yu","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hong-Hai","family":"You","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2021,4,2]]},"reference":[{"key":"R1-20250524","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<1::AID-AJMG3>3.0.CO;2-8","article-title":"Epidemiology of neurofibromatosis type 1","volume":"89","author":"Friedman","year":"1999","journal-title":"Am J Med Genet"},{"key":"R2-20250524","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1634\/theoncologist.2010-0181","article-title":"Neoplasms associated with germline and somatic NF1 gene mutations","volume":"17","author":"Patil","year":"2012","journal-title":"Oncologist"},{"key":"R3-20250524","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/j.jocn.2010.02.015","article-title":"Glioblastoma of the cerebellum and brainstem","volume":"17","author":"Stark","year":"2010","journal-title":"J Clin Neurosci"},{"key":"R4-20250524","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s11060-017-2682-7","article-title":"Characteristics of cerebellar glioblastomas in adults","volume":"136","author":"Picart","year":"2018","journal-title":"J Neurooncol"},{"key":"R5-20250524","first-page":"1","article-title":"Cerebellar glioblastoma in an NF1 patient. Is it surgical debulking really necessary?","author":"Flower","year":"2019","journal-title":"Br J Neurosurg"},{"key":"R6-20250524","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/neup.12579","article-title":"Glioblastoma in adults with neurofibromatosis type I: a report of two cases","volume":"39","author":"Narasimhaiah","year":"2019","journal-title":"Neuropathology"},{"key":"R7-20250524","doi-asserted-by":"crossref","first-page":"779","DOI":"10.4103\/1793-5482.181119","article-title":"Giant Cell Glioblastoma in a Child with Clinical and Family History of Neurofibromatosis","volume":"12","author":"Pant","year":"2017","journal-title":"Asian J Neurosurg"},{"key":"R8-20250524","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.2147\/OTT.S50208","article-title":"Personalized treatment strategies in glioblastoma: MGMT promoter methylation status","volume":"6","author":"Thon","year":"2013","journal-title":"Onco Targets Ther"},{"key":"R9-20250524","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1111\/j.1440-1827.2005.01835.x","article-title":"Adenoid glioblastoma arising in a patient with neurofibromatosis type-1","volume":"55","author":"Miyata","year":"2005","journal-title":"Pathol Int"},{"key":"R10-20250524","doi-asserted-by":"crossref","first-page":"36","DOI":"10.14791\/btrt.2014.2.1.36","article-title":"Glioblastoma in a patient with neurofibromatosis type 1: a case report and review of the literature","volume":"2","author":"Jeong","year":"2014","journal-title":"Brain Tumor Res Treat"},{"key":"R11-20250524","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4103\/ajns.AJNS_274_16","article-title":"Malignant conversion to glioblastoma in neurofibromatosis type i-associated pleomorphic xanthoastrocytoma: unknown predictors of favorable outcome","volume":"13","author":"Singla","year":"2018","journal-title":"Asian J Neurosurg"},{"key":"R12-20250524","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s10014-017-0302-z","article-title":"Glioblastoma in neurofibromatosis 1 patients without IDH1, BRAF V600E, and TERT promoter mutations","volume":"35","author":"Shibahara","year":"2018","journal-title":"Brain Tumor Pathol"},{"key":"R13-20250524","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/S1548-5315(11)70509-5","article-title":"Glioblastoma multiforme in an adult with von Recklinghausen disease","volume":"5","author":"Mehta","year":"2008","journal-title":"Community Oncol"},{"key":"R14-20250524","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1212\/WNL.0000000000008623","article-title":"NF1 glioblastoma clonal profiling reveals KMT2B mutations as potential somatic oncogenic events","volume":"93","author":"Wong","year":"2019","journal-title":"Neurology"},{"key":"R15-20250524","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature07385","article-title":"Comprehensive genomic characterization defines human glioblastoma genes and core pathways","volume":"455","year":"2008","journal-title":"Nature"},{"key":"R16-20250524","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1002\/pbc.22462","article-title":"Clinicopathologic study of glioblastoma in children with neurofibromatosis type 1","volume":"54","author":"Huttner","year":"2010","journal-title":"Pediatr Blood Cancer"},{"key":"R17-20250524","doi-asserted-by":"crossref","first-page":"344","DOI":"10.4103\/1793-5482.162728","article-title":"A rare case of neurofibromatosis - type 1","volume":"10","author":"Varghese","year":"2015","journal-title":"Asian J Neurosurg"},{"key":"R18-20250524","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1046\/j.1468-1331.2001.00320.x","article-title":"Neurofibromatosis and glioblastoma in a case of multiple sclerosis","volume":"8","author":"P\u00e1l","year":"2001","journal-title":"Eur J Neurol"},{"key":"R19-20250524","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1007\/BF01411565","article-title":"High-intensity lesion on T1-weighted MR images in neurofibromatosis type 1: a case of premalignant lesion","volume":"139","author":"Miaux","year":"1997","journal-title":"Acta Neurochir (Wien)"},{"key":"R20-20250524","first-page":"362","article-title":"Case report on a patient with neurofibromatosis type 1 and a frontal cystic glioblastoma","volume":"42","author":"Hakan","year":"2008","journal-title":"Neurol Neurochir Pol"},{"key":"R21-20250524","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/jcpt.12378","article-title":"Prolonged disease control with MEK inhibitor in neurofibromatosis type I-associated glioblastoma","volume":"41","author":"Ameratunga","year":"2016","journal-title":"J Clin Pharm Ther"},{"key":"R22-20250524","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1007\/s00415-014-7292-0","article-title":"Prolonged survival in adult neurofibromatosis type I patients with recurrent high-grade gliomas treated with bevacizumab","volume":"261","author":"Theeler","year":"2014","journal-title":"J Neurol"},{"key":"R23-20250524","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0883073810379639","article-title":"Association of rapidly progressive moyamoya syndrome with bevacizumab treatment for glioblastoma in a child with neurofibromatosis type 1","volume":"26","author":"Ullrich","year":"2011","journal-title":"J Child Neurol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025346","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T17:10:37Z","timestamp":1748106637000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000025346"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2021,4,2]]},"references-count":23,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000025346","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,2]]},"assertion":[{"value":"2020-12-27","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-03-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}